Clinical Trial Update: Pemetrexed as First Line Chemotherapy for Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pemetrexed as first-line chemotherapy for advanced breast cancer. The study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pemetrexed (pemetrexed)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED